Global Autoimmune Disease Diagnostics Market to Surpass US$10 Billion by 2032 Rising Driven by Disease Burden and Personalized Testing
Industry Experts, Inc. has introduced its latest market research report, "Autoimmune Disease Diagnostics - A Global Market Overview," estimating that worldwide revenues will rise from US$6.2 billion in 2025 to US$10.2 billion by 2032, growing at a CAGR of 7.5% during 2025 to 2032. Market expansion is driven by the rising global prevalence of more than 100 autoimmune disorders, including rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes, coupled with heightened awareness, early testing initiatives, and technological advancements in immunoassays, biomarkers, and molecular diagnostics.
Advances in genomics, proteomics, bioinformatics, and AI-driven automation are significantly improving sensitivity, specificity, and turnaround time across diagnostic platforms. Growing adoption of multiplex and next-generation sequencing assays, together with machine-learning–based interpretation tools, is enabling precision diagnostics and personalized medicine. The rise of point-of-care and at-home testing further expands access to rapid and cost-effective screening, while collaborations between pharmaceutical and diagnostic companies foster development of targeted assays and companion diagnostics. Increasing healthcare investment, aging populations, and broader use of telemedicine continue to underpin market demand.

North America leads the global autoimmune disease diagnostics market with a 40.9% share in 2025, supported by high disease prevalence, favorable reimbursement, and strong R&D infrastructure. The Asia-Pacific region will record the fastest growth, posting a CAGR of 8.7% through 2032, driven by expanding healthcare infrastructure, national screening programs, and increased adoption of advanced immunoassay and molecular technologies. China accounts for the largest share in the region, while India exhibits the highest growth momentum with affordable local test kits and rising awareness.
By product, Reagents & Consumables dominate with a 67.2% share in 2025, reflecting recurring demand for ELISA, CLIA, and multiplex assay components used in routine monitoring and biomarker testing. The Instruments segment will expand the fastest at a CAGR above 8%, propelled by automation, high-throughput immunoassay platforms, and digital integration for precision diagnostics. By disease type, Systemic Autoimmune Diseases command a 62.9% share in 2025 and the highest 7.9% CAGR, led by rheumatoid arthritis, lupus, and multiple sclerosis requiring multiplexed antibody panels and continuous monitoring. Localized Autoimmune Diseases, led by type 1 diabetes, also show strong potential through improved antibody and molecular assays.
By test type, Antinuclear Antibody (ANA) Tests hold the largest share at 30.9% in 2025, supported by their vital role in early screening and monitoring. Autoantibodies and Immunologic Tests will record the fastest 8.3% CAGR, driven by multiplexing, AI-enabled automation, and personalized diagnostic approaches.
The report segments the global Autoimmune Disease Diagnostics market by product (reagents & consumables, instruments), disease type (systemic, localized), and test type (ANA tests, autoantibody & immunologic tests, CBC, CRP, urinalysis, and others) across five major geographic regions. The study includes analysis of 15 companies, such as Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Danaher (Beckman Coulter), Roche, Siemens Healthineers, Quest Diagnostics, and Thermo Fisher Scientific.
For sample pages or purchase options, contact +1-320-497-3787 or visit Autoimmune Disease Diagnostics Market Report.
About Industry Experts, Inc.
Industry Experts, Inc. ranks among the leading market research providers globally. The company's off-the-shelf and customized business-intelligence reports offer strategic insights and valuable guidance to enable corporate strategists, analysts, researchers, and startups to obtain unbiased current and future market data. For more information, contact +1-320-497-3787 or visit https://industry-experts.com.
Comments
Post a Comment